AstraZeneca Pharma India Limited (BOM:506820)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	245,433	215,159	133,010	81,183	63,886	75,255
Market Cap Growth	27.97%	61.76%	63.84%	27.07%	-15.11%	25.87%
Enterprise Value	240,428	210,362	127,861	76,552	60,484	72,857
Last Close Price	9817.30	8577.01	5284.39	3211.62	2520.50	2967.13
PE Ratio	133.88	185.90	82.35	81.76	103.71	80.66
PS Ratio	13.23	12.54	10.27	8.09	7.93	9.25
PB Ratio	31.86	27.93	18.68	13.79	12.49	16.50
P/TBV Ratio	31.89	27.95	18.74	13.79	12.49	16.50
P/FCF Ratio	-	338.25	777.38	163.12	70.07	77.53
P/OCF Ratio	-	329.19	477.25	139.27	63.38	71.82
EV/Sales Ratio	12.96	12.26	9.87	7.63	7.51	8.96
EV/EBITDA Ratio	83.13	84.67	69.81	47.45	73.16	54.94
EV/EBIT Ratio	98.06	97.93	74.58	51.43	87.20	62.67
EV/FCF Ratio	-	330.71	747.29	153.81	66.33	75.06
Debt / Equity Ratio	0.05	0.05	0.01	0.01	0.02	0.03
Debt / EBITDA Ratio	0.12	0.14	0.02	0.04	0.10	0.09
Debt / FCF Ratio	-	0.56	0.27	0.14	0.10	0.13
Asset Turnover	-	1.32	1.26	1.09	0.99	1.10
Inventory Turnover	-	2.50	2.87	2.22	2.11	1.85
Quick Ratio	-	1.05	1.89	1.61	1.64	1.46
Current Ratio	-	1.91	2.61	2.18	2.12	2.04
Return on Equity (ROE)	-	15.62%	24.84%	18.05%	12.73%	22.74%
Return on Assets (ROA)	-	10.34%	10.39%	10.11%	5.32%	9.81%
Return on Capital (ROIC)	20.13%	17.64%	16.33%	16.67%	8.77%	17.21%
Return on Capital Employed (ROCE)	-	26.40%	23.80%	24.80%	13.20%	24.70%
Earnings Yield	0.75%	0.54%	1.21%	1.22%	0.96%	1.24%
FCF Yield	-	0.30%	0.13%	0.61%	1.43%	1.29%
Dividend Yield	0.34%	0.37%	0.45%	0.50%	0.40%	0.07%
Payout Ratio	-	51.84%	24.77%	20.14%	8.12%	5.36%
Total Shareholder Return	0.29%	0.37%	0.45%	0.50%	0.40%	0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.